Neurological impairment and arthritis in an immunocompetent child with human parvovirus B19 chronic infection

Infezioni in Medicina

Volumn 18, Issue 3, 2010, Pages 187-190

  Bozzola, Elena ^a   Krzysztofiak, Andrzej ^a   Cortis, Eisabetta ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Arthritis; Children; Human parvovirus B19; Neurological impairment

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTHRITIS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CHILD; CLINICAL EXAMINATION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOCOMPETENCE; INFECTION; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SERODIAGNOSIS; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANKLE JOINT; ARTHRITIS, INFECTIOUS; CHILD; CHRONIC DISEASE; ERYTHEMA INFECTIOSUM; HEADACHE; HUMANS; IMMUNOCOMPETENCE; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYRADICULONEUROPATHY; REFLEX, ABNORMAL; VIREMIA;

EID: 78049524679     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Servey J.T., Reamy B.V., Hodge J. Clinical presentation of parvovirus B19 infection. Am. Fam. Physician 75(3), 373-376, 2007.
2. Koch C.W. Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr.Opin.Infect.Dis.14, 343-356, 2001.
3. Young N.S., Brown K.E. Parvovirus B19. N. Engl. J. Med. 350, 586-597, 2004.
4. Barah F., Valley P.J., Cleator G.M., Kerr J.R. Neurological manifestations of human parvovirus B19 infection. Rev. Med. Virol. 13, 185-199, 2003.
5. Minohara Y., Koitabashi Y., Kato T. et al. A case of Guillain- Barrè Syndrome associated with human parvovirus B19 infection. J. Infect. 36(3), 327-328, 1998.
6. Yamaoka Y., Isozaki E., Kagamihara Y., Matsubara S., Hirai S., Takagi K. A case of Guillan-Barre syndrome (GBS) following human parvovirus B19 infection. Rinsho Shinkeigaku. 40(5), 471-475, 2000.
7. Grillo E., da Silva R.J. Childhood chorea-encephalopathy and unremarkable MRI: an association suggesting parvovirus B19 infection. Dev. Med. Child Neurol. 51(9), 759-761, 2009.
8. Fong C.Y., de Sousa C. Childhood chorea-encephalopathy associated with human parvovirus B19 infection. Dev. Med. Child Neurol. 48, 526-28, 2006.
9. Hartley L.M., Ng S.Y., Dale R.C., Church A.J., Martinez A., de Sousa C. Immune mediated chorea encephalopathy syndrome in childhood. Dev. Med. Child Neurol. 44, 273-277, 2002.
10. Douvoyiannis M., Litman N., Goldman D.L. Neurologic manifestations associated with parvovirus B19 infection. Clin. Infect. Dis. 15, 48(12), 1713-1723, 2009.
11. Coskun O., Erdem H., Gul H.C., Besirbellioglu B.A., Sener K., Eyigun C.P. Meningoencephalitis associated with human parvovirus B19. Clin. Microbiol. Infect. 14(12), 1188-1190, 2008.
12. Florea A.V., Ionescu D.N., Melhem M.F. Parvovirus B19 infection in the immunocompromised host. Arch. Pathol. Lab. Med. 131(5), 799-804, 2007.
13. Peterlana D., Puccetti A., Corrocher R., Lunardi C. Serological and molecular detection of human Parvovirus B 19 infection. Clin. Chim. Acta 372, 14-23, 2006.
14. Bassols A.C. Parvovirus B19 and the new century. Clin. Infect. Dis. 15, 46(4), 537-539, 2008.
15. Beersma M.F., Claas E.C., Sopaheluakan T., Kroes A.C. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. J. Clin. Virol. 34(1), 71-75, 2005.
16. Mani B., Gerber M., Lieby P., Boschetti N., Kempf C., Ros C. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses. Transfusion 47(10), 1765-1774, 2007.
17. Takano T., Yamada K. Quantitation of human parvovirus B19 DNA by real-time polymerase chain reaction. Pediatr. Int. 49(4), 459-462, 2007.
18. Lehmann H.W., Plentz A., von Landenberg P., Muller-Godeffroy E., Modrow S. Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies. Arthritis Res. Ther. 6, R1-R6, 2004.
19. Nigro G., D'Eufemia P., Zerbini M., Krzysztofiak A., Finocchiaro R., Giardini O. Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy. Pediatr. Infect. Dis. J. 13(11), 1019-1021, 1994.